健保碼及健保價 |
See related Multaq film-coated tab[脈泰克 膜衣錠] information |
|
製造商 |
Sanofi-aventis |
代理/經銷商 |
Sanofi-aventis |
成份 |
Dronedarone HCl |
適應症 |
Treatment of atrial fibrillation (AF) or arterial flutter (AFL), with a recent episode of AF/AFL & associated CV risk factors (age >70, HTN, diabetes, prior cerebrovascular accident, left atrial diameter ≥50 mm or left ventricular ejection fraction [LVEF] <40%), who are in sinus rhythm or who will be cardioverted. |
用量 |
Adult 400 mg bid. |
過量 |
View Multaq[脈泰克] overdosage for action to be taken in the event of an overdose. |
用法 |
Should be taken with food (Avoid grapefuit juice.). |
禁忌 |
Severe CHF (Stage NYHA IV) & other unstable hemodynamic conditions; 2nd- or 3rd-degree AV block or sick sinus syndrome (except when used in conjunction with a functioning pacemaker); bradycardia <50 bpm; co-administration with strong CYP3A4 inhibitors eg ketoconazole, itraconazole, voriconazole, cyclosporin, telithromycin, clarithromycin, nefazodone & ritonavir; co-administration with drugs inducing torsades de pointes eg phenothiazines, tricyclic antidepressants, certain oral macrolides, class I & III antiarrhythmics; QTc Bazett interval ≥500 msec; severe hepatic impairment. Pregnancy & lactation. |
注意事項 |
May induce QT prolongation. Patients with moderate CHF (Stage NYHA III). Correct K or Mg deficiency before & during therapy. Monitor plasma creatinine. |
不良反應 |
Diarrhea, nausea, vomiting, fatigue, asthenia, abdominal pain, dyspepsia, bradycardia, rashes, pruritis.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
交互作用 |
β-blockers, Ca antagonists, digoxin; phenothiazines, bepridil, TCAs, certain oral macrolides, class I & III antiarrhythmics; doxorubicin, fexofenadine, talinolol; rifampicin, phenobarbital, carbamazepine, phenytoin; ketoconazole, itraconazole, voriconazole, ritonavir, cyclosporin, telithromycin, clarithromycin; sirolimus & tacrolimus; simvastatin, lovastatin, atorvastatin, pravastatin; theophylline; warfarin
View more drug interactions with Multaq[脈泰克] |
儲存 |
View Multaq[脈泰克] storage conditions for details to ensure optimal shelf-life. |
描述 |
View Multaq[脈泰克] description for details of the chemical structure and excipients (inactive components). |
作用 |
View Multaq[脈泰克] mechanism of action for pharmacodynamics and pharmacokinetics details. |
本商品之市售規格 |
|
Manufacturer: |
Sanofi-aventis |
Distributor: |
Sanofi-aventis |
|
|
|
|